April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Profile of Lipid and Protein Autocoids in Diabetic Vitreous Correlates with the Progression of Diabetic Retinopathy
Author Affiliations & Notes
  • K. Gotlinger
    Pharmacology,
    New York Medical College, Valhalla, New York
  • M. Laniado Schwartzman
    Pharmacology,
    Ophthalmology,
    New York Medical College, Valhalla, New York
  • M. W. Dunn
    Pharmacology,
    Ophthalmology,
    New York Medical College, Valhalla, New York
  • M. Sartore
    Ospedale Sacro Cuore, Negrar (VR), Italy
  • G. Pertile
    Ospedale Sacro Cuore, Negrar (VR), Italy
  • A. Leonardi
    Neuroscience, University of Padua, Padua, Italy
  • S. Sathe
    Optometry, SUNY College of Optometry, New York, New York
  • L. Trieu
    Optometry, SUNY College of Optometry, New York, New York
  • R. Sack
    Optometry, SUNY College of Optometry, New York, New York
  • Footnotes
    Commercial Relationships  K. Gotlinger, None; M. Laniado Schwartzman, None; M.W. Dunn, None; M. Sartore, None; G. Pertile, None; A. Leonardi, None; S. Sathe, None; L. Trieu, None; R. Sack, None.
  • Footnotes
    Support  Supported in part by NIH grants EY06513 and HL34300 (MLS)
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 1330. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K. Gotlinger, M. Laniado Schwartzman, M. W. Dunn, M. Sartore, G. Pertile, A. Leonardi, S. Sathe, L. Trieu, R. Sack; Profile of Lipid and Protein Autocoids in Diabetic Vitreous Correlates with the Progression of Diabetic Retinopathy. Invest. Ophthalmol. Vis. Sci. 2009;50(13):1330.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : The vitreous is a sink accumulating lipids and proteins with a paracrine function from the retina. This study was aimed at obtaining partial profile of these entities in the normal and diabetic vitreous (V) and exploring whether their presence correlates with retinal pathology.

Methods: : Central V samples were recovered during vitrectomy from individuals without retinal detachment (control), with retinal detachment but without an underlying diabetic retinopathy (NDR), with proliferative (PDR) and non-proliferative (NPDR) diabetic retinopathy. Lipid autocoid profiles were determined by mass spectrometry-based lipidomics using a triple quadruple linear ion trap LC/MS/MS system and multiple reaction monitoring of specific transition ions. Proteins were screened for 40+ angiogenic modulators and selected proteins were targeted for quantitative analysis (QA) using protein arrays.

Results: : Lipid autocoid profiles reveal the presence of arachidonic acid (AA)-derived 5-hydroxyeicosatetraenoic acid (HETE), 15-HETE and 19-HETE and the docosahexaenoic acid (DHA)-derived resolvin 4-HDHA in the diabetic but not the control samples. Only the levels of 5-HETE, a product of 5-lipoxygenase (LOX), was more than 2 times higher in NPDR as compared to PDR patients (109.66±17.49 vs. 46.13±9.92 pg/mg protein, p=0.005). Protein array analysis revealed marked differences in the distribution of numerous angiogenic modulators in the control vs the pathological samples with a pattern suggesting that retinal detachment contributes to many of these changes. QA reveals, however, marked differences in the concentration range of specific proteins in the different sets of samples.

Conclusions: : The diabetic vitreous contains elevated levels of many angiogenic proteins with some of these changes attributable to retinal detachment and other changes associated with diabetic progression. In contrast, the lipidomic changes appear to be diabetic-specific. Lipoxygenases are regulators of chronic inflammation and oxidative stress generation. A recent study showed that diabetes-induced retinopathy was significantly reduced in 5-LOX-deficient mice (Gubitosi-Klug et al, 2008). 5-HETE is the initial AA metabolite of the 5-LOX cascade; its increased levels may be an index of elevated inflammatory and oxidative processes, which underlie the pathogenesis of diabetic retinopathy.

Keywords: diabetic retinopathy • vitreous • eicosanoids 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×